Series A - AnaCardio
Investment Firm
Overview
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Announced Date
Sep 07, 2022
Funding Type
Series A
Highlights
Location
Europe
Social
Participant Investors
2
| Investor Name |
|---|
 Industrifonden |
Round Details and Background
AnaCardio raised $14012919 on 2022-09-07 in Series A
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 07, 2022 |  Series A - AnaCardio | 3 | - | 14.0M |
| Feb 03, 2022 | Debt Financing - AnaCardio | 4 | - | 3.6M |
| Jun 17, 2021 | Seed Round - AnaCardio | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.